1. Home
  2. TCRX vs GTE Comparison

TCRX vs GTE Comparison

Compare TCRX & GTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCRX
  • GTE
  • Stock Information
  • Founded
  • TCRX 2018
  • GTE 2003
  • Country
  • TCRX United States
  • GTE Canada
  • Employees
  • TCRX N/A
  • GTE N/A
  • Industry
  • TCRX Biotechnology: Pharmaceutical Preparations
  • GTE Oil & Gas Production
  • Sector
  • TCRX Health Care
  • GTE Energy
  • Exchange
  • TCRX Nasdaq
  • GTE Nasdaq
  • Market Cap
  • TCRX 140.7M
  • GTE 158.1M
  • IPO Year
  • TCRX 2021
  • GTE N/A
  • Fundamental
  • Price
  • TCRX $1.92
  • GTE $3.77
  • Analyst Decision
  • TCRX Strong Buy
  • GTE
  • Analyst Count
  • TCRX 5
  • GTE 0
  • Target Price
  • TCRX $9.40
  • GTE N/A
  • AVG Volume (30 Days)
  • TCRX 648.1K
  • GTE 406.5K
  • Earning Date
  • TCRX 11-07-2025
  • GTE 10-30-2025
  • Dividend Yield
  • TCRX N/A
  • GTE N/A
  • EPS Growth
  • TCRX N/A
  • GTE N/A
  • EPS
  • TCRX N/A
  • GTE N/A
  • Revenue
  • TCRX $6,961,000.00
  • GTE $621,677,000.00
  • Revenue This Year
  • TCRX $255.18
  • GTE $5.03
  • Revenue Next Year
  • TCRX N/A
  • GTE N/A
  • P/E Ratio
  • TCRX N/A
  • GTE N/A
  • Revenue Growth
  • TCRX N/A
  • GTE N/A
  • 52 Week Low
  • TCRX $1.02
  • GTE $3.34
  • 52 Week High
  • TCRX $6.23
  • GTE $8.19
  • Technical
  • Relative Strength Index (RSI)
  • TCRX 41.52
  • GTE 40.29
  • Support Level
  • TCRX $2.23
  • GTE $4.15
  • Resistance Level
  • TCRX $2.43
  • GTE $4.20
  • Average True Range (ATR)
  • TCRX 0.19
  • GTE 0.21
  • MACD
  • TCRX -0.04
  • GTE -0.05
  • Stochastic Oscillator
  • TCRX 1.52
  • GTE 12.23

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

Share on Social Networks: